These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Membranoproliferative glomerulonephritis associated with multicentric angiofollicular lymph node hyperplasia. Case report and review of the literature. Said R; Tarawneh M Am J Nephrol; 1992; 12(6):466-70. PubMed ID: 1292348 [TBL] [Abstract][Full Text] [Related]
3. Remission of nephrotic syndrome after thalidomide therapy in a patient with Castleman's disease. Menegato MA; Canelles MF; Tonutti E; Pizzolitto S Clin Nephrol; 2004 May; 61(5):352-6. PubMed ID: 15182131 [TBL] [Abstract][Full Text] [Related]
4. Membranoproliferative glomerulonephritis in Castleman's disease: a systematic review of the literature and 2 case reports. Zhang H; Wang R; Wang H; Xu Y; Chen J Intern Med; 2012; 51(12):1537-42. PubMed ID: 22728487 [TBL] [Abstract][Full Text] [Related]
5. A case of Castleman's disease complicated with nephrotic syndrome due to glomerulopathy mimicking membranoproliferative glomerulonephritis. Sugimoto T; Ito J; Takeda N; Gasyu I; Okazaki T; Sakaguchi M; Osawa N; Tanaka Y; Oka K; Uzu T; Kashiwagi A Am J Med Sci; 2008 Jun; 335(6):495-8. PubMed ID: 18552583 [TBL] [Abstract][Full Text] [Related]
6. Multicentric Castleman's disease associated with glomerular microangiopathy and MPGN-like lesion: does vascular endothelial cell-derived growth factor play causative or protective roles in renal injury? Seida A; Wada J; Morita Y; Baba M; Eguchi J; Nishimoto N; Okino T; Ichimura K; Yoshino T; Makino H Am J Kidney Dis; 2004 Jan; 43(1):E3-9. PubMed ID: 14712466 [TBL] [Abstract][Full Text] [Related]
7. Castleman's disease and mesangial proliferative glomerulonephritis: the role of interleukin-6. Lui SL; Chan KW; Li FK; Cheng IK; Chan TM Nephron; 1998; 78(3):323-7. PubMed ID: 9546694 [TBL] [Abstract][Full Text] [Related]
8. Rapidly progressive renal failure associated with angiofollicular lymph node hyperplasia. Tsukamoto Y; Hanada N; Nomura Y; Hiki Y; Kasai K; Shigematsu H; Kobayashi Y Am J Nephrol; 1991; 11(5):430-6. PubMed ID: 1809043 [TBL] [Abstract][Full Text] [Related]
9. End-stage renal failure from renal amyloidosis of the AA type associated with giant lymph node hyperplasia (Castleman's disease). Montoli A; Minola E; Stabile F; Grillo C; Radaelli L; Spanti D; Luccarelli E; Spata C; Minetti L Am J Nephrol; 1995; 15(2):142-6. PubMed ID: 7733151 [TBL] [Abstract][Full Text] [Related]
10. Membranous nephropathy associated with multicentric Castleman's disease that was successfully treated with tocilizumab: a case report and review of the literature. Saiki R; Katayama K; Hirabayashi Y; Oda K; Fujimoto M; Murata T; Nakajima A; Dohi K BMC Nephrol; 2021 Jun; 22(1):216. PubMed ID: 34107915 [TBL] [Abstract][Full Text] [Related]
11. A case of multicentric Castleman's disease with membranoproliferative glomerulonephritis type 3-like lesion. Nagai K; Usui J; Noguchi K; Unai K; Hiwatashi A; Arakawa Y; Togashi A; Morito N; Saito C; Yoh K; Tsuruoka S; Kojima H; Aita K; Nagata M; Yamagata K Pathol Int; 2011 Nov; 61(11):686-90. PubMed ID: 22029682 [TBL] [Abstract][Full Text] [Related]